ErbB2/CEP17 and total ErbB2 copy number as independent forecast factor for time to First Metastasis (TTM) and with a trastuzumab-based therapy in HER2 testing metasase breast cancer [abstract]

Attems, J;, Fuchs, EM;, Kostler, WJ;, Horvat, R;, Hudelist, G;, Dressler, C;, Pfeiler, G;, Fink-Retter, A;, Gschwantler-Kaulich, D;, Zielinski, CC;, Singer, CF

ErbB2/CEP17 and total ErbB2 copy number as independent forecast factor for time to First Metastasis (TTM) and with a trastuzumab-based therapy in HER2 testing metasase breast cancer [abstract]

Lookup NU author(s): Professor Johannes Attems

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Publication metadata

Author(s): Attems J; Fuchs EM; Kostler WJ; Horvat R; Hudelist G; Dressler C; Pfeiler G; Fink-Retter A; Gschwantler-Kaulich D; Zielinski CC; Singer CF

Publication type: Article

Publication status: Published

Journal: Geburtshilfe und Frauenheilkunde

Year: 2010

Volume: 70

Issue: 3

Pages: 245

ISSN (print): 0016-5751

ISSN (electronic): 1438-8804

Publisher: Georg Thieme Verlag

ePrints

ErbB2/CEP17 and total ErbB2 copy number as independent forecast factor for time to First Metastasis (TTM) and with a trastuzumab-based therapy in HER2 testing metasase breast cancer [abstract]

Downloads

Publication metadata

Share